Nonalcoholic steatohepatitis: pathologic features and differential diagnosis

被引：61
作者：
Brunt, Elizabeth M. [1 ]
机构：
[1] St Louis Univ, Sch Med, Ctr Liver, St Louis, MO USA
来源：
SEMINARS IN DIAGNOSTIC PATHOLOGY | 2005年 / 22卷 / 04期
关键词：
nonalcoholic; fatty liver disease; steatohepatitis;
D O I：
10.1053/j.semdp.2006.04.002
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
The worldwide epidemic of obesity has raised the awareness of nonalcoholic fatty liver disease (NAFLD) from that of a curiosity to one of a potentially progressive liver disease with risk for cirrhosis and hepatocellular carcinoma. This overview is focused on the histopathology of the spectrum of fatty liver disease, and discusses the role of liver biopsy, differential diagnoses, and new techniques in development. When pertinent, pathophysiology of this metabolic liver disease and recent treatment considerations have been mentioned as well. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码：330 / 338
页数：9
相关论文
共 93 条
  • [51] Beyond insulin resistance in NASH:: TNF-α or adiponectin?
    Hui, JM
    Hodge, A
    Farrell, GC
    Kench, JG
    Kriketos, A
    George, J
    [J]. HEPATOLOGY, 2004, 40 (01) : 46 - 54
  • [52] Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression
    Hui, JM
    Sud, A
    Farrell, GC
    Bandara, P
    Byth, K
    Kench, JG
    McCaughan, GW
    George, J
    [J]. GASTROENTEROLOGY, 2003, 125 (06) : 1695 - 1704
  • [53] ITOH S, 1987, AM J GASTROENTEROL, V82, P650
  • [54] Design and validation of a histological scoring system for nonalcoholic fatty liver disease
    Kleiner, DE
    Brunt, EM
    Van Natta, M
    Behling, C
    Contos, MJ
    Cummings, OW
    Ferrell, LD
    Liu, YC
    Torbenson, MS
    Unalp-Arida, A
    Yeh, M
    McCullough, AJ
    Sanyal, AJ
    [J]. HEPATOLOGY, 2005, 41 (06) : 1313 - 1321
  • [55] Prediction of liver fibrosis in patients with features of the metabolic syndrome regardless of alcohol consumption
    Lainé, F
    Bendavid, C
    Moirand, R
    Tessier, S
    Perrin, M
    Guillygomarc'h, A
    Guyader, D
    Calon, E
    Renault, A
    Brissot, P
    Turlin, B
    Deugnier, Y
    [J]. HEPATOLOGY, 2004, 39 (06) : 1639 - 1646
  • [56] AMIODARONE HEPATOTOXICITY - PREVALENCE AND CLINICOPATHOLOGIC CORRELATIONS AMONG 104 PATIENTS
    LEWIS, JH
    RANARD, RC
    CARUSO, A
    JACKSON, LK
    MULLICK, F
    ISHAK, KG
    SEEFF, LB
    ZIMMERMAN, HJ
    [J]. HEPATOLOGY, 1989, 9 (05) : 679 - 685
  • [57] Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial
    Lindor, KD
    Kowdley, KV
    Heathcote, EJ
    Harrison, ME
    Jorgensen, R
    Angulo, P
    Lymp, JF
    Burgart, L
    Colin, P
    [J]. HEPATOLOGY, 2004, 39 (03) : 770 - 778
  • [58] Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease
    Lonardo, A
    Adinolfi, LE
    Loria, P
    Carulli, N
    Ruggiero, G
    Day, CP
    [J]. GASTROENTEROLOGY, 2004, 126 (02) : 586 - 597
  • [59] LUDWIG J, 1980, MAYO CLIN PROC, V55, P434
  • [60] Lutchman G, 2005, GASTROENTEROLOGY, V128, pA695
12345678910